Clinical Trial Update: Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity [Phase 4]

View source ↗

Summary

A Phase 4 trial update compares the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NORVASC (amlodipine besylate)
• Ranexa (ranolazine)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN